ClinicalTrials.Veeva

Menu
I

Instituto Oncologico de Cordoba | Cordoba, Argentina

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Nivolumab
BMS-936558
Anastrozole
Docetaxel
Exemestane
Tamoxifen
Ipilimumab
Bevacizumab
Dacarbazine
Atezolizumab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 9 total trials

A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

This study is being done to see if a drug called disitamab vedotin, alone or with pembrolizumab, works to treat HER2 expressing urothelial cancer. It...

Enrolling
Urothelial Carcinoma
Drug: pembrolizumab
Drug: disitamab vedotin

TOL2506A (OVELIA) is a Phase 3, single arm, open-label study evaluating the effectiveness of TOL2506 in suppressing ovarian function in premenopausal...

Invitation-only
Breast Cancer
Drug: Exemestane Tablets
Drug: Anastrozole Tablets

Trial sponsors

Bristol-Myers Squibb (BMS) logo
Boehringer Ingelheim logo
N
Roche logo
T
S

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems